| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3383243 | Reumatología Clínica | 2010 | 4 Pages |
Abstract
There does not seem to be a trend regarding different risks in BIOBADASER 2.0 with respect to the general registry, or to previous years.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Miguel Ángel Descalzo, Loreto Carmona, Grupo de Estudio BIOBADASER Grupo de Estudio BIOBADASER,